As the market transitions from a fearful tone to bullish optimism, some stocks may struggle to keep up, underperforming even ...

Beyond Inc. is on of our top picks for 2025. Why do we believe analyst FY25 revenue estimates are overly pessimistic? Click ...

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...

Introduction - Issuers listed on the Nasdaq Stock Market and the New York Stock Exchange (NYSE) often conduct reverse stock splits to ...

Markets across Asia staged a relief rally after President Trump postponed tariffs on Canada and Mexico. Both Japanese and ...

Holdings announced the date of effectiveness and the ratio of a forthcoming reverse stock split of the Company’s Common ...

Benchmark equity indices Sensex and Nifty make a U-turn to trade in the negative territory on Budget day. Investors keenly tracked Finance Minister Nirmala Sitharaman plan for the economy. Union ...

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...

Investors looking for growth in a reversal market may find the stock underperforming, as the change in trend is difficult to ignore. Therefore, it is wise to tread carefully with this one during ...

The Company anticipates that the reverse stock split will increase the market price per share of the Company’s common stock, bringing the Company into compliance with The Nasdaq Capital Market ...